Anixa Biosciences Inc (NASDAQ:ANIX)

1.36
Delayed Data
As of Mar 27
 -0.28 / -17.18%
Today’s Change
1.33
Today|||52-Week Range
5.45
-58.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues255.0K300.0K362.5K1.1M
 
 
 
 
 
Cost of Goods Sold147.7K77.9K91.5K750.0K
 
 
 
 
 
Depreciation And Amortization325.3K358.6K368.5K343.7K
 
 
 
 
 
 
Operating ExpensesGross Income-218.0K-136.5K-97.5K18.8K
 
 
 
 
 
General Expenses6.2M4.3M6.0M13.7M
 
 
 
 
 
Other Operating Expenses0.000.0013.1K0.00
 
 
Research And Development--1.6M1.6M6.8M
 
 
 
 
Total Operating Expenses6.7M4.7M6.4M14.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.4M-4.4M-6.1M-13.7M
 
 
 
 
 
Extraordinary Credit5.5M0.001.5M0.00
 
 
 
Extraordinary Charge0.00-106.2K0.00-583.0K
 
 
 
Interest Expense On Debt451.9K519.9K500.5K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-5.0M-5.0M-14.2M
 
 
 
 
 
Minority Interest0.000.000.00-247.1K
 
 
Preferred Dividend0.00---2.0M0.00
 
 
Net Income-1.4M-5.0M-5.0M-14.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.8M8.7M12.2M17.6M
 
 
 
 
 
Shares To Calculate EPS Diluted8.8M8.7M12.2M17.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.57-$0.58-$0.79
 
 
 
 
 
EPS Diluted-$0.16-$0.57-$0.58-$0.79